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Background: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder in women. The
developmental competence of oocytes and embryos in PCOS patients is reduced to a certain extent (comparing to
non-PCOS patients, the high quality embryo rate was decreased by 16% from the data of our centre) during the
in vitro fertilization (IVF) process. Cross-talk between the oocyte and cumulus cells is critical for oocyte maturation
and embryo competence. In this study, we have evaluated the transcription of specific genes in cumulus cells
harvested from pre-ovulatory follicles of PCOS patients before IVF, according to individual oocyte nuclear maturity
and developmental competence. Seven genes (RUNX2, PSAT1, ADAMTS9, CXCL1, CXCL2, CXCL3, and ITGB5) were
targeted from our previous cDNA microarray data which isolated genes related to oocyte nuclear maturation in
PCOS patients. Two additional genes which had been found to be associated with oocyte maturation or embryo
quality in non-PCOS patients (GPX3 and PTX3) were also studied.
Methods: The mRNA expression levels of cumulus cells were detected by qRT- PCR.
Results: Consistent with our previous cDNA microarray data, with the exception of GPX3 and PTX3, the selected 7
genes were related to oocyte nuclear maturation in PCOS patients. Noticeably, the expression level of RUNX2 was
lower in cumulus cells derived from oocytes that could develop into blastocysts than the level of expression from
oocytes that could not. The PTX3 expression level was significantly lower in cumulus cells from oocytes with two
normal pronuclei than that from oocytes that formed >2 pronuclei (MPN) after fertilization. GPX3 mRNA levels were
decreased in cumulus cells isolated from oocytes that developed into blastocysts with high potential development
competence.
Conclusions: Several cumulus cell genes were associated with oocyte maturation, fertilization and embryo quality
in PCOS patients. RUNX2 and GPX3 are candidate genetic markers in the monitoring of embryo quality for PCOS
patients, whereas PTX3 mainly played a role in fertilization process. Together with morphological evaluation,
cumulus cells genes may serve as biomarkers of oocyte and embryo selection during the IVF process for PCOS
patients and may advance our understanding of PCOS.
Keywords: Embryo development, Fertilization, Gene expression, Human cumulus cells, Oocyte maturation, PCOS* Correspondence: cuifanghao@aliyun.com
1Reproductive Medicine Centre, Affiliated Hospital of Qingdao Medical
University, Yuhuangding Hospital of Yantai, 20 Yuhuangding Road East,
Yantai, Shandong, China
Full list of author information is available at the end of the article
© 2013 Huang et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Huang et al. Reproductive Biology and Endocrinology 2013, 11:109 Page 2 of 10
http://www.rbej.com/content/11/1/109Background
Polycystic ovary syndrome (PCOS) is a common endocrine
and metabolic disorder in women [1-3] which is character-
ized by increased circulating androgen levels, anovulatory
infertility, and, frequently, insulin resistance and hyperin-
sulinemia. During in vitro fertilization (IVF), although suf-
ficient oocytes are usually retrieved from PCOS patients
who are under controlled ovarian stimulation (COS), high-
quality mature oocytes are limited in number [4-7]. The
paucity of high-quality mature oocytes may result from
endocrine and intra-ovarian paracrine interactions in PCOS
patients which could change the microenvironment for
oocyte development during the folliculogenesis and reduce
the developmental competence of oocytes [8,9]. Follicular
growth and maturation are prerequisites to oocyte fertili-
zation and subsequent early embryo development [10-12].
In antral follicles, granulosa cells line the follicle wall,
whereas cumulus cells encircle the oocyte to form the
cumulus-oocyte-complex (COC). Cross-talk between cu-
mulus cells (CCs) and oocytes in the follicle is understood
to be a pivotal process in oocyte maturation and metabol-
ism [13,14]. The impact of the oocyte-cumulus cell rela-
tionships on both maturation and fertilization ability have
been well-established [15,16]. Previous researchers have
reported that gene expressions of CCs could be used as a
tool to predict oocyte competence or embryo develop-
ment [14,17-24].
In our previous report [25], the expression levels of
59 genes exhibited significant differences during different
phases of nuclear maturation (MII and MI) in CCs of
PCOS patients. The results may indicate that the expres-
sion of these CCs genes are associated with oocyte matur-
ation in PCOS patients. Moreover, several genes (LHCGR,
TNIK and SOCS3) may serve as biomarkers of embryo
competence in CCs of PCOS patients. To evaluate the
roles of other genes in the CCs of PCOS patients during
developmental processes, including oocyte maturation,
fertilization and embryo development, we analysed a panel
of 9 genes. Seven of these genes, [Runt-related transcrip-
tion factor 2 (RUNX2), Phosphoserine aminotransferase 1
(PSAT1), ADAM metallopeptidase with thrombospondin
type 1 motif 9 (ADAMTS9), chemokine (C-X-C motif)
ligand 1,2,3 (CXCL1, CXCL2, CXCL3), and integrin β5
(ITGB5)] were chosen based on differences in their ex-
pression at different oocyte nuclear maturity stages (MII
or MI) in cumulus cells of PCOS patients [25]. Another
two genes [glutathione peroxidase 3 (GPX3) and pentraxin
3 (PTX3)] were selected because they have previously been
related to oocyte maturation or embryo quality [11,18,22].
The aim of this study was to evaluate the expression
of these genes in cumulus cells from PCOS patient dur-
ing different developmental stages (oocyte maturation,
fertilization and blastocyst formation). The results would
help us identify whether the developmental competenceof the oocytes/ embryos of PCOS patients are related
to the specific expression patterns of these genes and
whether these genes are clinically important and could
offer a new potential strategy for selecting competent
oocytes or embryos in PCOS patients.
Methods
Patients and IVF treatment
This project was approved by the Institutional Ethical
Review Board of Affiliated Hospital of Qingdao Medical
University (Yuhuangding Hospital of Yantai). PCOS patients
referred to our center for in vitro fertilization (IVF)
were included in this study after written informed
consent. All of the PCOS patients were characterized
by the presence of two or more of the following features:
chronic oligo-ovulation or anovulation, androgen excess
and polycystic ovaries. We excluded patients with Cushing’s
syndrome, congenital adrenal hyperplasia, and androgen-
secreting tumors. The inclusion criteria of the recruited
PCOS patients in this study were as follows: age ranging
between 30 and 38 years, BMI ranging between 20 and
26 kg/m2, number of obtained oocytes ranging between
13 and 19 per cycle, number of obtained blastocysts
ranging between 4 and 9 per cycle, basal serum LH/FSH
more than 2.0, serum androgen more than 0.5 ng/ml, and
normal spermiogram of the partner according to the
WHO criteria. Ovarian stimulation and oocyte retrieval
protocols were performed as our previously described in
all PCOS patients [25].
Retrieval of cumulus cells
The method of retrieving cumulus cells and the process of
oocyte insemination and culture were performed as de-
scribed previously [25]. In brief, after COC retrieval, a
proportion of the CCs surrounding a single oocyte were re-
moved using a sharp needle, lysed in 80 ml of RLT buffer
(RNeasy Mini Kit, Qiagen) supplemented with 1% (v/v) 2-β-
mercaptoethanol (M-3148; Sigma, Lyon, France), and stored
at −80°C (CCs from one oocyte per vial) until RNA extrac-
tion. Oocytes were further inseminated and embryos were
cultured in sequential media of SAGE (CooperSurgical,
Leisegang Medical, Berlin) individually in 20 ul droplets
covered by mineral oil. Embryos were transferred or vitri-
fied on Day 3 and the other embryos were cultured to blas-
tula stage on Day 5–6.
Assessment of oocyte and embryo quality
The morphological characteristics of the oocytes and em-
bryos were individually recorded. Oocytes were denudated
to assess the maturation stage 3 h after insemination. The
oocytes were first classified into two categories based on
nuclear status: (i) Immature MI oocytes exhibiting no polar
bodies (PB) or immature oocytes at the germinal vesicle
stage (GV), and (ii) mature MII oocytes that extruded a
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after insemination and zygotes were classified into two
groups: (i) oocyte exhibiting normal fertilization (2 pro-
nuclei, 2PN) and (ii) oocyte exhibiting abnormal fertili-
zation (more than 2 pronuclei, MPN). Oocytes with no
pronuclei (0PN) were discarded. On Day 2 (44–46 h post-
IVF), individually cultured embryos were evaluated accord-
ing to the number of blastomeres, the fragmentation rate
and the presence of multinucleated blastomeres. Embryos
with one or several multinucleated blastomeres and un-
cleaved embryos were excluded. On Day 3, embryos
containing at least 7 cells, <10% fragmentation and no
multinucleated blastomeres were classified as ‘top quality
embryo (TQE)’. Others were classified as ‘weak or low
grade embryo (WLGE)’ [24]. Two or three embryos were
transplanted into the uterus of patients on Day 3, whereas
the others were frozen or cultured to the blastocyst stage.
The blastocysts were scored on the expansion of the15 PCOS patients 
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Figure 1 Distribution tree of COCs involved in the study. A total of 21
which are atretic or with fractured zones pellucidae were discarded, there
On Day 1 (16–18 hours after insemination), 130 CCs separated from oocyte
oocytes with abnormal fertilization (MPN) were classed into a “CC2PN” and
developed from oocytes with normal fertilization (2PN) were transplanted o
subgroups randomly. The other 73 embryos were cultured to the blastocys
in vitro culture were classified as the “CCB+” group (n = 37), and cumulus ce
Day 6 were divided into “CCB-” groups (n = 36). COC, cumulus-oocyte-comp
oocyte; CCMII, cumulus cells from MII oocyte; CC0PN, cumulus cells from ooc
cells from oocyte which formed two pronuclei (2PN) after fertilization; CCM
after fertilization; CCWLGE, cumulus cells from oocyte yielding a weak or low
top quality embryo at Day 3; CCB-, cumulus cells from oocyte which stoppe
from oocyte yielding a blastocyst after 5/6 days of in vitro culture.blastocoel cavity, the cohesiveness of the inner cell mass,
and trophectodermal cells [26]. The best blastocyst quality
on Day 5, i.e. blastocyst score 1 = BL 3–5, AA or AB (inner
cell mass/ trophectoderm , ICM/TE) with ≤10% fragmen-
tation. The good blastocyst quality on Day 5, blastocyst
score 1 or 2 with score 2 = BL 1,2 or BL 3–5 with BA or
BB (ICM/TE score) with ≤20% fragmentation.
Experimental design and the groups of cumulus cells
According to different stages of oocytes or embryos, the
corresponding cumulus cells were divided into different
groups, viz.: CCMI/GV, CCMII, CC2PN, CCMPN, CCB+, CCB-.
Each group had ≥3 replicates. Each subgroup, containing
9–12 cumulus cells, represented a biological replicate. The
distribution of the collected COCs is depicted in Figure 1.
In our experiment, a total of 212 COCs were retrieved
from the 15 PCOS patients. Among these COCs, only 3
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there were ten CCMI and one CCGV. On Day 1 (16–18 hours
after insemination), 130 CCs separated from oocytes with
normal fertilization (2PN) and 36 CCs separated from
mature oocytes with abnormal fertilization (MPN) were
classed into a “CC2PN” and “CCMPN” group, respectively.
On Day 3, 54 of 127 embryos that developed from oocytes
with normal fertilization (2PN) were transplanted or
frozen and their corresponding CCs were classified
into 6 subgroups of CC2PN while the other 73 embryos
were cultured to the blastocyst stage. In each subgroup,
there are 9 cumulus cells randomly from 3 or 4 PCOS
patients. Cumulus cells from oocytes yielding blastulas
(top or good blastocyst quality)after 5–6 days in culture
were classified as the “CCB+” group (n = 37), and cumulus
cells from oocytes that arrested at the cleavage stage after
Day 6 were divided into “CCB-” groups (n = 36). The
number of CCs and biological replicates in the different
groups are shown in Table 1.
RNA extraction and reverse transcription
The cumulus cells of each subgroup were pooled together
to extract total RNA and were analysed individually. Total
RNA isolation was performed using the Qiagen RNeasy
Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. This RNA isolation kit signifi-
cantly reduces contamination from both genomic DNA
and proteins. The RNA quality was assessed using an
Agilent 2100 Bioanalyzer (Agilent Technologies, Kista,
Sweden). Only samples with RNA integrity number (RIN)
>6.0 in the cumulus cells subgroups were included. A
good correlation between RIN values >5.5 and the out-
come of a real-time PCR experiment has been shown and
RIN values ≥ 5.5 are considered as high quality [27]. The
first-strand complementary synthesis reaction was per-
formed using the PrimeScript RT reagent Kit (Perfect Real
time; TaKaRa Biotechnology, Dalian, China).
qRT-PCR
qRT-PCR was performed on 9 genes (RUNX2, PSAT1,
ADAMTS9, CXCL1, CXCL2, CXCL3, ITGB5, GPX3 and
PTX3). Primers for all the target genes were designed
using the Universal Probe Library software (RocheTable 1 The number of CCs and biological replicates in
different groups






CCB- 36 3Diagnostics, Roche Applied Science) and were chosen to
be intron spanning. Amplification reactions were con-
ducted using SYBR Premix Ex Taq (Perfect Real Time)
(TaKaRa Biotechnology, Dalian, China) and an ABI PRISM
7300 system. The gene-specific qRT-PCR primers used are
listed in Table 2. To normalize the expression level, the
housekeeping gene GAPDH was used because its expres-
sion was stable in all CCs groups. The PCR thermal cycling
conditions were 95°C for 10 min for polymerase activation
and the initial denaturation step, followed by 40 cycles with
denaturation at 95°C for 15 s, annealing at 60°C for 60 s
and extension at 72°C for 30 s. A melting curve analysis
was recorded at the end of the amplification to evaluate
the absence of contaminants or primer dimers. Each set of
qRT-PCR reactions was repeated three times, and the fold
change in the expression of each gene was analysed using
the DDCt method [28].
Statistical analysis
Student’s t-test of independent data was used for statis-
tical analysis (SPSS Inc., Chicago, IL). The differences
among groups were considered significant when the
p-value was <0.05.
Results
Transcripts levels of the target genes according to oocyte
nuclear maturity in PCOS patients
In the CCMII (n = 173) compared to CCMI/GV (n = 33)
groups (Figure 2), mean transcript levels of three genes
were significantly higher, with 2.18-, 3.37- and 2.26- fold
increases observed for RUNX2 (2.14 ± 0.63 versus 0.98 ±
0.33), PSAT1 (4.38 ± 0.92 versus 1.3 ± 0.3), and ADAMTS9
(1.65 ± 0.3 versus 0.73 ± 0.23), respectively, whereas the
expression levels of four genes were significantly decreased
in the CCMII samples, with 4.05-, 4.21-, 6- and 3.27- fold de-
creases observed for CXCL1 (0.19 ± 0.09 versus 0.77 ± 0.26),
CXCL2 (0.19 ± 0.02 versus 0.8 ± 0.18), CXCL3 (0.16 ± 0.02
versus 0.96 ± 0.09) and ITGB5 (0.26 ± 0.03 versus
0.85 ± 0.13), respectively. The transcripts levels of the other
two genes (GPX3 and PTX3) exhibited no significant
differences between the CCMII and CCMI/GV groups.
Transcripts levels of the target genes according to the
fertilization process in PCOS patients
To evaluate whether target genes were involved in the
fertilization process, the transcript levels of the target genes
were detected in CC2PN (n = 130) and CCMPN (n = 36)
groups (Figure 3). The PTX3 expression level exhibits sig-
nificant differences between CCs isolated from oocytes
which formed two normal pronuclei (2PN) and that from
oocytes which formed more than two pronuclei (MPN)
after fertilization. The mean expression level of PTX3 was
2- fold lower in the CC2PN group than in the CCMPN group
Table 2 The primer sequences (5’-3’) used in qRT-PCR
Gene symbol Accession nr Forward primer Reversed primer Fragment length
GAPDH NM_002046 TGTTGCCATCAATGACCCCTT CTCCACGACGTACTCAGCG 202
RUNX2 NM_001015051.3 TCCAGGAGGACAGCAAGAAGT TGTCACTGTGCTGAAGAGGCT 182
PSAT1 NM_021154 .3 ATGGGCTTGGTTCTGGAGTG GGCCAGCTTCTGAACGTCTT 324
ADAMTS9 NM_182920.1 AGGGTCGTTTTAGCATCAACC TCCACAGTAACCACCGCATT 149
CXCL1 NM_001511.2 CCCAAACCGAAGTCATAGCC CCTTCAGGAACAGCCACCAG 158
CXCL2 NM_002089.3 CCCAAACCGAAGTCATAGCC CAGGAACAGCCACCAATAAGC 154
CXCL3 NM_002090.2 CACTCAAGAATGGGAAGAAAGC GCAGGAAGTGTCAATGATACGC 142
ITGB5 NM_002213.3 GACCGGAGGGAGTTTGCAA CCTCGGAGAAGGAAACATCAGT 170
GPX3 NM_002084.3 GGCTTTGTCCCTAATTTCCAG AAAGTTCCAGCGGATGTCGT 171
PTX3 NM_002852.3 GCATCTCCTTGCGATTCTGTT CATTCCGAGTGCTCCTGACC 165
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other 8 target genes exhibited no significantly changes.
Transcripts levels of the target genes according to
embryo development potential in PCOS patients
The transcripts levels of the target genes were then evalu-
ated according to the outcome of the normal fertilized oo-
cytes after 5–6 days of culture. Among the 9 target genes,
two genes (RUNX2 and GPX3) exhibited differential
expression between the CCB+ (n = 37) and CCB- (n = 36)
groups (Figure 4), whereas the other 7 genes exhibited
no significantly changes. The mean transcripts levels of
RUNX2 was decreased by 2.14- fold in the CCB+ group
compared with the CCB- group (0.44 ± 0.03 versus 0.94 ±
0.05), whereas the mean expression level of GPX3 was de-
creased by 3.18- fold in the CCB+ group compared with













Figure 2 Transcripts levels of the target genes (RUNX2, PSAT1, ADAMT
oocyte nuclear maturity in PCOS patients. mRNA expression of candida
and PTX3) in cumulus cells of PCOS patients, organized according to oocyt
intensity for each gene is shown on the y-axis in arbitrary units determined
* indicates a significant difference in gene expression between CC categories
CCMI/GV: cumulus cells from oocyte at the MI stage or GV stage; CCMII: cumuluDiscussion
PCOS is the most common heterogeneous endocrinopathy
in women of reproductive age. Although patients suffering
from PCOS benefit from assisted reproduction techniques
(ARTs), oocyte competence and the pregnancy rates are
compromised. Existing data demonstrates that oocyte
competence in PCOS patients is altered [4-7,29,30]. Im-
proving the competence of oocytes or embryos of PCOS
patients will raise their probability of pregnancy and re-
duce the risk of multiple gestations. To date, non-invasive
embryo selection has been based mainly on morphological
features including the polar body (PB), zona pellucida,
meiotic spindle, and cytoplasm. However, morphological
evaluation is not a reliable predictor of oocyte competence
and embryo quality [14]. Indeed, oocyte competence de-
pends on the quality of the follicular microenvironment,





S9, CXCL1, CXCL2, CXCL3, ITGB5, GPX3 and PTX3) according to
te genes (RUNX2, PSAT1, ADAMTS9, CXCL1, CXCL2, CXCL3, ITGB5, GPX3
e nuclear maturity stage (MI/GV stage versus MII stage). The signal
by qRT-PCR analysis with GAPDH as an endogeneous reference.
(** p < 0.01, * p < 0.05). The results are presented as the means ± SEM.





















Figure 3 Transcripts levels of the target genes (RUNX2, PSAT1, ADAMTS9, CXCL1, CXCL2, CXCL3, ITGB5, GPX3 and PTX3) according to the
fertilization process in PCOS patients. mRNA expression of candidate genes (RUNX2, PSAT1, ADAMTS9, CXCL1, CXCL2, CXCL3, ITGB5, GPX3 and
PTX3) in cumulus cells of PCOS patients, organized according to pronuclei formation after fertilization (normal two pronuclei versus multi
pronuclei). The signal intensity for each gene is shown on the y-axis in arbitrary units determined by qRT-PCR analysis with GAPDH as an
endogeneous reference. * indicates a significant difference in gene expression between CC categories (** p < 0.01, * p < 0.05). The results are
presented as the means ± SEM. CC2PN: cumulus cells from oocyte which formed two normal pronuclei (2PN) after fertilization; CCMPN, cumulus
cells from oocyte which formed multi pronuclei (MPN) after fertilization.
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http://www.rbej.com/content/11/1/109(CC)-oocyte signaling is critical for both oocyte and CC
competence acquisition [10-12,14,20]. In this respect, the
analysis of CCs, in conjunction with morphological cri-
teria, is an appropriate approach for oocyte or embryo
selection.
In our previous report [25], the expression levels of six
genes which mainly associated with different signal path-
ways [two genes involved in the neuroactive ligand–














Figure 4 Transcripts levels of the target genes (RUNX2, PSAT1, ADAMT
embryo quality in PCOS patients. mRNA expression of candidate genes (
cumulus cells of PCOS patients, organized according to oocyte developmen
is shown on the y-axis in arbitrary units determined by qRT-PCR analysis wit
ence in gene expression between CC categories (** p < 0.01, * p < 0.05). The
oocyte yielding blastocyst after 5–6 days of in vitro culture; CCB-: cumulus cgenes involved in the Wnt signaling pathway (SFRP4 and
TNIK), one gene involved in the type 2 diabetes mellitus
pathway (SOCS3), and one gene mediating angiogenesis
(ANGPTL1)] were detected by qRT-PCR to evaluate whe-
ther they were related with oocyte/embryo quality. The
results indicated that the molecular signatures (LHCGR,
TNIK, and SOCS3) were associated with developmental po-
tential from embryo to blastocyst stage and were proposed
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RUNX2, PSAT1, ADAMTS9, CXCL1, CXCL2, CXCL3, ITGB5, GPX3 and PTX3) in
t capability after normal fertilization. The signal intensity for each gene
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results were presented as the means ± SEM. CCB+: cumulus cells from
ells from oocyte that had not developed into blastocyst at Day 5/6.
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seven genes which were mainly related with inflammatory
response and development [inflammation-related genes
(CXCL1, CXCL2, CXCL3), inflammation-related transcrip-
tion factor (RUNX2), development (ADAMTS9), amino
acid biosynthesis (PSAT1), cell-matrix adhesion (ITGB5)]
from our cDNA microarray data and another two genes
[glutathione peroxidase 3 (GPX3) and pentraxin 3 (PTX3)]
which were proved to be related with oocyte maturation
or embryo quality in previous reports were detected to in-
vestigate whether these genes were associated with em-
bryo developmental potential in PCOS patients. This
study is the second one in a row to evaluate the predictive
value of CC gene expression for oocyte/embryo quality
using qRT-PCR. Our hypothesis is that by this ‘cascade’
testing strategy, the strongest predictive genes which were
associated with embryo quality in PCOS patients may be
filtered out through the consecutive studies.
In the present research, the relative mRNA abundance
of the selected 7 genes (RUNX2, PSAT1, ADAMTS9,
CXCL1, CXCL2, CXCL3, ITGB5) in CCs isolated from
oocytes at different nuclear maturity stages (MII and
MI/GV) were consistent with our cDNA microarray data
[25]. Compared to the list of DEGs (n = 25) which were
related to oocyte nuclear maturity stage in non-PCOS
patients [10], we confirmed that these selected 7 genes
were all not identified in the Ouandaogo’s report. These
data may indicate that there are different molecular
mechanisms governing the process of oocyte nuclear
maturation in PCOS and non-PCOS patients. For GPX3
and PTX3, the expression levels of mRNA exhibited no
significant differences between the CC-MII and CC-MI/GV
groups in our research, and they were not included in
the candidate genes isolated from cumulus cells accord-
ing to oocyte nuclear maturity stages in non-PCOS pa-
tients [10]. These results suggested that GPX3 and PTX3
may play roles in biological process other than oocyte
nuclear maturity. We therefore investigated whether the
selected genes were involved in fertilization and embryo
development.
Genes were mainly associated with oocyte nuclear
maturation in PCOS patients
Among the selected nine genes, the expression levels of
six genes (PSAT1, ADAMTS9, CXCL1, CXCL2, CXCL3,
ITGB5) exhibited significant differences in CCs from oo-
cytes at different nuclear maturation stages. No change
was observed between the CC-2PN and CC-MPN groups
or between the CC-B+ and CC-B- groups. The results im-
plied that these genes may play roles during the oocyte
nuclear maturation progress. In our previous report [25],
the genes were identified as being involved in different
biological processes as follows: amino acid biosynthesis
(PSAT1), development (ADAMTS9), the inflammatoryresponse (CXCL1, CXCL2, CXCL3) and cell-matrix adhe-
sion (ITGB5).
The relative mRNA abundance of PSAT1and ADAMTS9
in cumulus cells from oocytes at the MII stage was higher
than that from oocytes at MI/GV stages. PSAT1, phospho-
serine aminotransferase, is an enzyme implicated in serine
biosynthesis and has been linked with cell proliferation
in vitro [31]. PSAT1 plays an important role in the G2/M
phase to modify the cell cycle and stimulate cell prolife-
ration [32]. ADAMTS9, a gene involved in extracellular
matrix binding, is widely expressed during mouse embryo
development [33]. Furthermore, the extracellular matrix
of CCs plays a major role in folliculogenesis and is crucial
for ovulation, oviduct passage, and fertilization [34].
Comparing the CC-MII group with the CC-MI/GV group,
the expression levels of four genes (CXCL1, CXCL2,
CXCL3, ITGB5) were decreased. To our knowledge, these
four genes, which are related with the inflammatory re-
sponse (CXCL1, CXCL2, CXCL3) or cell–matrix adhesion
(ITGB5), have been isolated from the CCs of PCOS pa-
tients for the first time by cDNA microarray in our previ-
ous research [25]. Though the role of chemokines during
oocyte maturation is unclear, previous researches have
demonstrated that the inflammatory response, which is in-
duced by other chemokines (such as IL-8), increases the
rates of meiotic arrest and the failure of germinal vesicle
breakdown [35]. Indeed, chemokines have been implicated
in a number of reproductive events, including ovulation,
menstruation, embryo implantation, and parturition and
disease conditions (i.e., endometriosis and cancer) [36,37].
ITGB5 (integrin beta 5) has also been implicated in cell
migration and angiogenesis during embryo implantation
due to its apical expression on glandular and luminal epi-
thelial cells [38]. Previous research has demonstrated that
the expression of ITGB5, which regulated by chemokines
(such as CX3CL1 and CCL14), could increase trophoblast
adherence and migration at the maternal-fetal interface
[39]. In the present research, we observed the same trend
(down-regulation) in mRNA expression of four genes
(CXCL1, CXCL2, CXCL3, ITGB5) during the oocyte mat-
uration process. Although it remains to be clarified whether
the expression of ITGB5 is regulated by chemokines
(CXCL1, CXCL2, CXCL3), our findings suggest that the ex-
pression of these genes in cumulus cells is negatively re-
lated to oocyte maturation and may be involved in embryo
implantation.
PTX3 may play an important role in the fertilization
process in PCOS patients
PTX3 is a downstream target gene of GDF9, which is a
member of the transforming growth factor-β superfamily
and plays an important role in promoting cumulus expan-
sion [40]. Cumulus expansion is a critical process for nor-
mal oocyte development, ovulation, and fertilization [41,42].
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http://www.rbej.com/content/11/1/109PTX3 co-localises with hyaluronic acid throughout the cu-
mulus matrix from the periphery to the zona pellucida and
interacts with tumour necrosis factor α-induced protein 6
(TNFAIP6) instead of binding directly to hyaluronan (HA)
[43]. Inactivation of PTX3 by targeted mutagenesis has
been reported to reduce the likelihood of fertilization, pos-
sibly through disruption of the structural integrity of the
cumulus complex [44]. The relationship between PTX3
levels and oocyte competence is, however, controversial.
Only Zhang and colleagues have reported that PTX3
mRNA levels exhibit significant differences between cu-
mulus cells derived from unfertilized oocytes and from oo-
cytes that developed to the eight-cell stage and led to the
establishment of clinical pregnancies [18]. In previous
studies, neither the PTX3 transcript level [17,45] nor the
PTX3 protein concentration in follicular fluid [46] ex-
hibited significant association with oocyte quality. Our
present results also show no significant difference between
cumulus cells isolated from oocytes at different nuclear
maturation stages (MII and MI stages) or cumulus cells
derived from oocytes with different developmental compe-
tence (embryos that could develop to blastocyst stage or
not). However, the PTX3 expression level exhibited signi-
ficant differences between cumulus cells isolated from
mature oocytes that formed two normal pronuclei or
multi- pronuclei after fertilization (CC-2PN and CC-MPN
groups). So, we speculated that PTX3 plays a key role in
the fertilization process instead of oocyte maturation or
embryo quality.RUNX2 and GPX3 may serve as biomarkers for embryo
selection in the CCs of PCOS patients
RUNX2 is a transcription factor that has been shown to
play a crucial role in cell differentiation. The expression
of RUNX2 was identified in rat ovary and was shown to
be increased by the luteinizing hormone (LH) surge in
preovulatory follicles and the luteal tissue [47]. Previous
reports have confirmed the strong relationship between
RUNX2 expression and ovulation, luteinization and ste-
roidogenesis [48]. Consistent with Papamentzelopoulou’s
findings [49], our data also proved that RUNX2 played
an antagonistic role in regulating embryo development
and could possibly be used as a genetic marker for pro-
jecting embryo quality. Recently, it was reported that the
expression level of RUNX2 was lower in the central
stroma of PCOS ovaries than in those of non-PCOS
ovaries. The results may have implications for the
PCOS-related defects in the inflammation-like ovulatory
process [50]. In our research, it is interesting that the
transcript level of RUNX2 to be higher in cumulus cells
derived from oocytes at the MII stage than in those at
the MI or GV stage of PCOS patients. Maybe the signifi-
cant difference of RUNX2 transcript levels betweenCCMII and CCMI/GV was also related with the defects of
inflammatory response in immature oocytes.
The expression level of GPX3 exhibited significant dif-
ference between the CC-B+ and CC-B- groups. Consist-
ent with previous researches which proved that GPX3
was related with embryo development or pregnancy out-
come [22,51], we observed that the expression level of
GPX3 was associated with embryo development and
could be a projector of embryo quality in PCOS patients.
GPX3 is regulated by hypoxia through HIF-1 binding
sites which detected only in glutathione peroxidase [52].
Hypoxia can induce the formation of reactive oxygen
species (ROS) which can cause lipid peroxidation, en-
zyme inactivation and cell damage, thereby, leading to
apoptosis [53]. This phenomenon occurs both in cumu-
lus cells and in the oocyte [54]. Moreover, the hypoxia
conditions and the higher concentration of ROS in fol-
licular fluid are negatively associated with embryonic de-
velopment and pregnancy outcomes [55,56]. Therefore,
GPX3 may indicate that hypoxic conditions could act as
a negative regulator of embryo development in PCOS
patients.
The strengths of this study were the well-diagnosed
PCOS women according to the Rotterdam criteria and the
cumulus cells were classified strictly according to the dif-
ferent development stages of oocyte/embryo. A limitation
of the study was that the cumulus cells in each subgroup
which derived from 3–4 PCOS patients were pooled to-
gether to extract RNA due to the total RNA purified from
a single cumulus is so limited. This may cause an imbal-
ance of the samples and limits the endpoints that can be
analyzed. But the imbalance of the samples could not be
avoided absolutely, unless all the cumulus cells were de-
rived from the same patient. Moreover, because PCOS is a
common heterogeneous endocrinopathy in women of re-
productive age, the molecular roles of target genes in the
development of oocyte/embryo need be further verified in
the large-scale PCOS patients.
Conclusions
In conclusion, our results support existing evidence that
the expression profiling of cumulus cells may be project
competence of oocytes and embryos. In our study, one
gene, RUNX2, accurately predicted both oocyte maturity
and embryo quality for PCOS patients. Two additional
genes (PTX3 and GPX3) were related to fertilization and
embryo quality in PCOS patients, respectively. Cumulus
cells, which are typically discarded during IVF, are there-
fore suitable for the determination of developmental po-
tential of the oocyte and embryo. For PCOS patients,
expression patterns of cumulus cells may provide an ob-
jective basis for embryo selection, and could further elu-
cidate the complex molecular mechanisms governing
oocyte and embryo development.
Huang et al. Reproductive Biology and Endocrinology 2013, 11:109 Page 9 of 10
http://www.rbej.com/content/11/1/109Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
XH and CFH devised the study and participated in its design. XH and YHZ
did the practical analysis, advised by CFH. XFS and XYL sampled the material
and cultured the embyros. XH wrote the manuscript. XH, CFH and YHZ
corrected the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This study was supported by the National Basic Research Program (grant
81170622), Science and Technology Development Project of Shangdong
Population and Family Planning Commission (grant 2011–15), and Science
and Technology Development Project of Yantai (grant 2010-148-26).
Author details
1Reproductive Medicine Centre, Affiliated Hospital of Qingdao Medical
University, Yuhuangding Hospital of Yantai, 20 Yuhuangding Road East,
Yantai, Shandong, China. 2CapitalBio Corporation Center (Biochip National
Engineering Research Center), Yantai Branch Center, 20 Yuhuangding Road
East, Yantai, Shandong, China.
Received: 28 August 2013 Accepted: 23 November 2013
Published: 26 November 2013
References
1. Franks S: Polycystic ovary syndrome. N Engl J Med 1995, 333:853–861.
2. Legro RS: Polycystic ovary syndrome: the new millenium. Mol Cell
Endocrinol 2001, 184:87–93.
3. Ehrmann DA: Polycystic ovary syndrome. N Engl J Med 2005, 352:1223–1236.
4. Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, McAllister JM,
Mosselman S, Strauss JF 3rd: The molecular phenotype of polycystic ovary
syndrome (PCOS) theca cells and new candidate PCOS genes defined by
microarray analysis. J Biol Chem 2003, 278:26380–26390.
5. Wood JR, Dumesic DA, Abbott DH, Strauss JF 3rd: Molecular abnormalities
in oocytes from women with polycystic ovary syndrome revealed by
microarray analysis. J Clin Endocrinol Metab 2007, 92:705–713.
6. Kwon H, Choi DH, Bae JH, Kim JH, Kim YS: mRNA expression pattern of
insulin-like growth factor components of granulosa cells and cumulus
cells in women with and without polycystic ovary syndrome according
to oocyte maturity. Fertil Steril 2010, 94:2417–2420.
7. Liu Y, Jiang H, He LY, Huang WJ, He XY, Xing FQ: Abnormal expression of
uncoupling protein-2 correlates with CYP11A1 expression in polycystic
ovary syndrome. Reprod Fertil Dev 2011, 23:520–526.
8. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L: Pregnancy outcomes
among women with polycystic ovary syndrome treated with metformin.
Hum Reprod 2002, 17:2858–2864.
9. Arredondo F, Noble LS: Endocrinology of recurrent pregnancy loss.
Semin Reprod Med 2006, 24:33–39.
10. Ouandaogo ZG, Haouzi D, Assou S, Dechaud H, Kadoch IJ, De Vos J,
Hamamah S: Human cumulus cells molecular signature in relation to
oocyte nuclear maturity stage. PLoS One 2011, 6:e27179.
11. Ouandaogo ZG, Frydman N, Hesters L, Assou S, Haouzi D, Dechaud H,
Frydman R, Hamamah S: Differences in transcriptomic profiles of human
cumulus cells isolated from oocytes at GV, MI and MII stages after
in vivo and in vitro oocyte maturation. Hum Reprod 2012, 27:2438–2447.
12. Gasca S, Pellestor F, Assou S, Loup V, Anahory T, Dechaud H, De Vos J,
Hamamah S: Identifying new human oocyte marker genes: a microarray
approach. Reprod Biomed Online 2007, 14:175–183.
13. Huang Z, Wells D: The human oocyte and cumulus cells relationship: new
insights from the cumulus cell transcriptome. Mol Hum Reprod 2010,
16:715–725.
14. Assou S, Haouzi D, De Vos J, Hamamah S: Human cumulus cells as
biomarkers for embryo and pregnancy outcomes. Mol Hum Reprod 2010,
16:531–538.
15. Cross PC, Brinster RL: In vitro development of mouse oocytes. Biol Reprod
1970, 3:298–307.
16. Goud PT, Goud AP, Qian C, Laverge H, Van der Elst J, De Sutter P, Dhont M:
In-vitro maturation of human germinal vesicle stage oocytes: role ofcumulus cells and epidermal growth factor in the culture medium.
Hum Reprod 1998, 13:1638–1644.
17. McKenzie LJ, Pangas SA, Carson SA, Kovanci E, Cisneros P, Buster JE, Amato
P, Matzuk MM: Human cumulus granulosa cell gene expression: a
predictor of fertilization and embryo selection in women undergoing
IVF. Hum Reprod 2004, 19:2869–2874.
18. Zhang X, Jafari N, Barnes RB, Confino E, Milad M, Kazer RR: Studies of gene
expression in human cumulus cells indicate pentraxin 3 as a possible
marker for oocyte quality. Fertil Steril 2005, 83(Suppl 1):1169–1179.
19. Feuerstein P, Cadoret V, Dalbies-Tran R, Guerif F, Bidault R, Royere D: Gene
expression in human cumulus cells: one approach to oocyte
competence. Hum Reprod 2007, 22:3069–3077.
20. Assou S, Haouzi D, Mahmoud K, Aouacheria A, Guillemin Y, Pantesco V,
Reme T, Dechaud H, De Vos J, Hamamah S: A non-invasive test for assessing
embryo potential by gene expression profiles of human cumulus cells: a
proof of concept study. Mol Hum Reprod 2008, 14:711–719.
21. Hamel M, Dufort I, Robert C, Gravel C, Leveille MC, Leader A, Sirard MA:
Identification of differentially expressed markers in human follicular cells
associated with competent oocytes. Hum Reprod 2008, 23:1118–1127.
22. van Montfoort AP, Geraedts JP, Dumoulin JC, Stassen AP, Evers JL, Ayoubi
TA: Differential gene expression in cumulus cells as a prognostic
indicator of embryo viability: a microarray analysis. Mol Hum Reprod 2008,
14:157–168.
23. Kenigsberg S, Bentov Y, Chalifa-Caspi V, Potashnik G, Ofir R, Birk OS: Gene
expression microarray profiles of cumulus cells in lean and overweight-
obese polycystic ovary syndrome patients. Mol Hum Reprod 2009, 15:89–103.
24. Adriaenssens T, Wathlet S, Segers I, Verheyen G, De Vos A, Van der Elst J,
Coucke W, Devroey P, Smitz J: Cumulus cell gene expression is associated
with oocyte developmental quality and influenced by patient and
treatment characteristics. Hum Reprod 2010, 25:1259–1270.
25. Huang X, Hao C, Shen X, Liu X, Shan Y, Zhang Y, Chen L: Differences in the
transcriptional profiles of human cumulus cells isolated from MI and MII
oocytes of patients with polycystic ovary syndrome. Reproduction 2013,
145:597–608.
26. Behr B, Pool TB, Milki AA, Moore D, Gebhardt J, Dasig D: Preliminary clinical
experience with human blastocyst development in vitro without
co-culture. Hum Reprod 1999, 14:454–457.
27. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M,
Lightfoot S, Menzel W, Granzow M, Ragg T: The RIN: an RNA integrity
number for assigning integrity values to RNA measurements.
BMC Mol Biol 2006, 7:3.
28. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using
real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods
2001, 25:402–408.
29. Dumesic DA, Abbott DH: Implications of polycystic ovary syndrome on
oocyte development. Semin Reprod Med 2008, 26:53–61.
30. Ludwig M, Finas DF, Al-Hasani S, Diedrich K, Ortmann O: Oocyte quality
and treatment outcome in intracytoplasmic sperm injection cycles of
polycystic ovarian syndrome patients. Hum Reprod 1999, 14:354–358.
31. Baek JY, Jun DY, Taub D, Kim YH: Characterization of human
phosphoserine aminotransferase involved in the phosphorylated
pathway of L-serine biosynthesis. Biochem J 2003, 373:191–200.
32. Vie N, Copois V, Bascoul-Mollevi C, Denis V, Bec N, Robert B, Fraslon C,
Conseiller E, Molina F, Larroque C, et al: Overexpression of phosphoserine
aminotransferase PSAT1 stimulates cell growth and increases
chemoresistance of colon cancer cells. Mol Cancer 2008, 7:14.
33. Jungers KA, Le Goff C, Somerville RP, Apte SS: Adamts9 is widely expressed
during mouse embryo development. Gene Expr Patterns 2005, 5:609–617.
34. Irving-Rodgers HF, Rodgers RJ: Extracellular matrix in ovarian follicular
development and disease. Cell Tissue Res 2005, 322:89–98.
35. Bromfield JJ, Sheldon IM: Lipopolysaccharide initiates inflammation in
bovine granulosa cells via the TLR4 pathway and perturbs oocyte
meiotic progression in vitro. Endocrinology 2011, 152:5029–5040.
36. Hannan NJ, Salamonsen LA: Role of chemokines in the endometrium and
in embryo implantation. Curr Opin Obstet Gynecol 2007, 19:266–272.
37. Dowsland MH, Harvey JR, Lennard TW, Kirby JA, Ali S: Chemokines and
breast cancer: a gateway to revolutionary targeted cancer treatments?
Curr Med Chem 2003, 10:579–592.
38. Aplin JD, Spanswick C, Behzad F, Kimber SJ, Vicovac L: Integrins beta 5,
beta 3 and alpha v are apically distributed in endometrial epithelium.
Mol Hum Reprod 1996, 2:527–534.
Huang et al. Reproductive Biology and Endocrinology 2013, 11:109 Page 10 of 10
http://www.rbej.com/content/11/1/10939. Hannan NJ, Salamonsen LA: CX3CL1 and CCL14 regulate extracellular
matrix and adhesion molecules in the trophoblast: potential roles in
human embryo implantation. Biol Reprod 2008, 79:58–65.
40. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM: Paracrine actions of
growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol
1999, 13:1035–1048.
41. Chang H, Brown CW, Matzuk MM: Genetic analysis of the mammalian
transforming growth factor-beta superfamily. Endocr Rev 2002, 23:787–823.
42. Vanderhyden BC, Macdonald EA, Nagyova E, Dhawan A: Evaluation of
members of the TGFbeta superfamily as candidates for the oocyte
factors that control mouse cumulus expansion and steroidogenesis.
Reprod Suppl 2003, 61:55–70.
43. Salustri A, Garlanda C, Hirsch E, De Acetis M, Maccagno A, Bottazzi B, Doni
A, Bastone A, Mantovani G, Beck Peccoz P, et al: PTX3 plays a key role in
the organization of the cumulus oophorus extracellular matrix and in
in vivo fertilization. Development 2004, 131:1577–1586.
44. Varani S, Elvin JA, Yan C, DeMayo J, DeMayo FJ, Horton HF, Byrne MC,
Matzuk MM: Knockout of pentraxin 3, a downstream target of growth
differentiation factor-9, causes female subfertility. Mol Endocrinol 2002,
16:1154–1167.
45. Cillo F, Brevini TA, Antonini S, Paffoni A, Ragni G, Gandolfi F: Association
between human oocyte developmental competence and expression
levels of some cumulus genes. Reproduction 2007, 134:645–650.
46. Pangas SA, Li X, Robertson EJ, Matzuk MM: Premature luteinization and
cumulus cell defects in ovarian-specific Smad4 knockout mice.
Mol Endocrinol 2006, 20:1406–1422.
47. Park ES, Lind AK, Dahm-Kahler P, Brannstrom M, Carletti MZ, Christenson LK,
Curry TE Jr, Jo M: RUNX2 transcription factor regulates gene expression in
luteinizing granulosa cells of rat ovaries. Mol Endocrinol 2010, 24:846–858.
48. Fan HY, Liu Z, Johnson PF, Richards JS: CCAAT/enhancer-binding proteins
(C/EBP)-alpha and -beta are essential for ovulation, luteinization, and the
expression of key target genes. Mol Endocrinol 2011, 25:253–268.
49. Papamentzelopoulou M, Mavrogianni D, Dinopoulou V, Theofanakis H,
Malamas F, Marinopoulos S, Bletsa R, Anagnostou E, Kallianidis K, Loutradis
D: Detection of RUNX2 gene expression in cumulus cells in women
undergoing controlled ovarian stimulation. Reprod Biol Endocrinol 2012,
10:99.
50. Schmidt J, Weijdegard B, Mikkelsen AL, Lindenberg S, Nilsson L, Brannstrom
M: Differential expression of inflammation-related genes in the ovarian
stroma and granulosa cells of PCOS women. Mol Hum Reprod 2013.
Aug 20. [Epub ahead of print].
51. Wathlet S, Adriaenssens T, Segers I, Verheyen G, Van Landuyt L, Coucke W,
Devroey P, Smitz J: Pregnancy prediction in single embryo transfer cycles
after ICSI using QPCR: validation in oocytes from the same cohort.
PLoS One 2013, 8:e54226.
52. Bierl C, Voetsch B, Jin RC, Handy DE, Loscalzo J: Determinants of human
plasma glutathione peroxidase (GPx-3) expression. J Biol Chem 2004,
279:26839–26845.
53. Buttke TM, Sandstrom PA: Oxidative stress as a mediator of apoptosis.
Immunol Today 1994, 15:7–10.
54. Tatemoto H, Sakurai N, Muto N: Protection of porcine oocytes against
apoptotic cell death caused by oxidative stress during In vitro
maturation: role of cumulus cells. Biol Reprod 2000, 63:805–810.
55. Pasqualotto EB, Agarwal A, Sharma RK, Izzo VM, Pinotti JA, Joshi NJ, Rose BI:
Effect of oxidative stress in follicular fluid on the outcome of assisted
reproductive procedures. Fertil Steril 2004, 81:973–976.
56. Das S, Chattopadhyay R, Ghosh S, Goswami SK, Chakravarty BN, Chaudhury
K: Reactive oxygen species level in follicular fluid–embryo quality marker
in IVF? Hum Reprod 2006, 21:2403–2407.
doi:10.1186/1477-7827-11-109
Cite this article as: Huang et al.: RUNX2, GPX3 and PTX3 gene
expression profiling in cumulus cells are reflective oocyte/embryo
competence and potentially reliable predictors of embryo
developmental competence in PCOS patients. Reproductive Biology and
Endocrinology 2013 11:109.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
